Beckman Coulter Selling $600M Worth of Senior Notes
 
Beckman Coulter this week said that it is offering $600 million worth of 2.5 percent senior convertible notes due 2036.
 
The offering, which includes a $75 million over-allotment option that has already been exercised, will net Beckman proceeds of $586 million.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.